Groww Logo
Home>IPO>Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals IPO

Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
To be announced------
Issue SizeIPO Doc
NA
DRHP PDF

About Emcure Pharmaceuticals

Emcure Pharmaceutical is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing, and gl
Parent Organisation
Emcure Pharmaceuticals Ltd.
Founded
1981
Managing Director
Satish Mehta

Strengths & Risks

  • Emcure’s core strength lies in its ability to research, develop, and manufacture in-house niche pharmaceutical products for high-growth therapeutic areas, for which there is limited competition and high barriers to entry.
  • Well-positioned to leverage leading position in the domestic market.
  • Large, diversified, and fast-growing product portfolio in the international markets.
  • Strong capabilities and a proven track record in building brands.
  • Extensive and diversified manufacturing capacity.
  • De-risked business model with a diversified income base.
  • Highly qualified, experienced, and entrepreneurial management team and board.
  • Business model focused on the compliance of Environmental, Social, and Governance (ESG) norms.
  • Any manufacturing or quality control problems.
  • Any delay, interruption, or reduction in the supply or transportation of its raw materials or finished products.
  • Slowdown or shutdown in its manufacturing or R&D operations.
  • Adverse order, including the imposition of penalties, in an investigation instituted by the Competition Commission of India against Emcure and others, alleging cartelization in the marketing of an oral anti-diabetes formulation.
  • Failure to obtain, maintain or renew its statutory and regulatory licenses, permits, and approvals required to operate its business.
  • Inability to accurately forecast demand for its products and manage its inventory.
  • Pricing pressure from customers may affect its ability to maintain or increase its product prices.
  • Significant proportion of its revenue is derived from its sale of products in certain therapeutic areas in India, such as the gynecology and cardiovascular therapeutic areas.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Top IPO FAQs

What is the issue size of Emcure Pharmaceuticals IPO?

Emcure Pharmaceuticals IPO issue size is a fresh issue of Rs 1100 crores and an offer for sale of up to 18,168,356 Equity Shares of Re.1

What is 'pre-apply' for Emcure Pharmaceuticals IPO?

Pre-apply will alow you to apply for the Emcure Pharama IPO 2 days before the subscription period starts.

If I pre-apply for Emcure Pharmaceuticals IPO, when will my order get placed?

Your order will be placed on the exchange as soon as the Emcure IPO bidding starts. You will receive a UPI request within 24 hours after the bidding period opens.

When will I know if my Emcure Pharmaceuticals IPO order is placed?

We will notify you when your Emcure Pharama IPO order is placed with the exchange.

What are the open and close dates of the Emcure Pharmaceuticals IPO?

Emcure IPO date is yet to be announced.

What is the lot size and minimum order quantity of the Emcure Pharmaceuticals IPO?

The minimum order quantity and lot size of Emcure Pharmaceuticals Limited are yet to be announced.

What are the allotment dates for the Emcure Pharmaceuticals IPO?

Emcure IPO allotment date is yet to be announced.

Who is the registrar of Emcure Pharmaceuticals IPO?

Emcure Pharmaceuticals IPO registrar is Link Intime India Private Ltd

Where is the Emcure Pharmaceuticals IPO getting listed?

The shares are proposed to be listed on the BSE and NSE.
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 2.4.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

ABOUT GROWW